These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15582469)

  • 1. Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases.
    Ganesh VK; Muller N; Judge K; Luan CH; Padmanabhan R; Murthy KH
    Bioorg Med Chem; 2005 Jan; 13(1):257-64. PubMed ID: 15582469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
    Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
    Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
    Nitsche C; Steuer C; Klein CD
    Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture.
    Steuer C; Gege C; Fischl W; Heinonen KH; Bartenschlager R; Klein CD
    Bioorg Med Chem; 2011 Jul; 19(13):4067-74. PubMed ID: 21641807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
    Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
    Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the West Nile virus protease substrate specificity and inhibitors.
    Mueller NH; Yon C; Ganesh VK; Padmanabhan R
    Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K; Pianwanit S; Sippl W; Kokpol S
    J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity.
    Doan DN; Li KQ; Basavannacharya C; Vasudevan SG; Madhusudhan MS
    Protein Eng Des Sel; 2012 Dec; 25(12):843-50. PubMed ID: 22972763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
    Murthy HM; Judge K; DeLucas L; Padmanabhan R
    J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dual-purpose synthetic colloidal platform for protease mapping: substrate profiling for Dengue and West Nile virus proteases.
    Marcon L; Kozak D; Battersby BJ; Chappell KJ; Fairlie DP; Young P; Trau M
    Anal Biochem; 2008 May; 376(1):151-3. PubMed ID: 18312847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold.
    Aravapalli S; Lai H; Teramoto T; Alliston KR; Lushington GH; Ferguson EL; Padmanabhan R; Groutas WC
    Bioorg Med Chem; 2012 Jul; 20(13):4140-8. PubMed ID: 22632792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation.
    Robin G; Chappell K; Stoermer MJ; Hu SH; Young PR; Fairlie DP; Martin JL
    J Mol Biol; 2009 Feb; 385(5):1568-77. PubMed ID: 19059417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease.
    Su XC; Ozawa K; Yagi H; Lim SP; Wen D; Ekonomiuk D; Huang D; Keller TH; Sonntag S; Caflisch A; Vasudevan SG; Otting G
    FEBS J; 2009 Aug; 276(15):4244-55. PubMed ID: 19583774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.
    Tiew KC; Dou D; Teramoto T; Lai H; Alliston KR; Lushington GH; Padmanabhan R; Groutas WC
    Bioorg Med Chem; 2012 Feb; 20(3):1213-21. PubMed ID: 22249124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold.
    Aleshin AE; Shiryaev SA; Strongin AY; Liddington RC
    Protein Sci; 2007 May; 16(5):795-806. PubMed ID: 17400917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors.
    Knox JE; Ma NL; Yin Z; Patel SJ; Wang WL; Chan WL; Ranga Rao KR; Wang G; Ngew X; Patel V; Beer D; Lim SP; Vasudevan SG; Keller TH
    J Med Chem; 2006 Nov; 49(22):6585-90. PubMed ID: 17064076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
    Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
    Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites.
    Othman R; Kiat TS; Khalid N; Yusof R; Newhouse EI; Newhouse JS; Alam M; Rahman NA
    J Chem Inf Model; 2008 Aug; 48(8):1582-91. PubMed ID: 18656912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
    Melino S; Paci M
    FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.